Donna Whyte-Steward, MD, reported in her contributing thesis that participants in the SIT trial (n = 340) with silent cerebral infarcts had significantly lower levels of Hpx than patients without silent cerebral infarcts (p = 0.0082). Here, HPX is linked to cerebral infarction.